Business Description
Kuros Biosciences Ltd
ISIN : CH0325814116
Description
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.27 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 40.31 | |||||
| Beneish M-Score | -2.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 76.8 | |||||
| 3-Year EBITDA Growth Rate | 6.9 | |||||
| 3-Year EPS without NRI Growth Rate | 6.8 | |||||
| 3-Year FCF Growth Rate | 13.6 | |||||
| 3-Year Book Growth Rate | -15.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.21 | |||||
| 9-Day RSI | 72.64 | |||||
| 14-Day RSI | 71.51 | |||||
| 6-1 Month Momentum % | 182.55 | |||||
| 12-1 Month Momentum % | 579.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.73 | |||||
| Quick Ratio | 2.17 | |||||
| Cash Ratio | 1.17 | |||||
| Days Inventory | 178.65 | |||||
| Days Sales Outstanding | 45.68 | |||||
| Days Payable | 58.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.9 | |||||
| Shareholder Yield % | -0.05 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.14 | |||||
| Operating Margin % | -17.55 | |||||
| Net Margin % | -16.91 | |||||
| FCF Margin % | -6.21 | |||||
| ROE % | -14.74 | |||||
| ROA % | -11.74 | |||||
| ROIC % | -18.69 | |||||
| 3-Year ROIIC % | 27.95 | |||||
| ROC (Joel Greenblatt) % | -162.58 | |||||
| ROCE % | -12.32 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 19 | |||||
| PB Ratio | 16.55 | |||||
| Price-to-Tangible-Book | 52.21 | |||||
| EV-to-EBIT | -129.39 | |||||
| EV-to-EBITDA | -194.82 | |||||
| EV-to-Revenue | 19.18 | |||||
| EV-to-FCF | -305.44 | |||||
| Price-to-Median-PS-Value | 2.25 | |||||
| Price-to-Net-Current-Asset-Value | 61.7 | |||||
| Earnings Yield (Greenblatt) % | -0.77 | |||||
| FCF Yield % | -0.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kuros Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 52.542 | ||
| EPS (TTM) (CHF) | -0.25 | ||
| Beta | 0.02 | ||
| Volatility % | 107.07 | ||
| 14-Day RSI | 71.51 | ||
| 14-Day ATR (CHF) | 1.203583 | ||
| 20-Day SMA (CHF) | 23.553 | ||
| 12-1 Month Momentum % | 579.56 | ||
| 52-Week Range (CHF) | 2.79 - 27.8 | ||
| Shares Outstanding (Mil) | 37.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kuros Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kuros Biosciences Ltd Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kuros Biosciences Ltd Frequently Asked Questions
What is Kuros Biosciences Ltd(CHIX:KURNz)'s stock price today?
The current price of CHIX:KURNz is CHF27.15. The 52 week high of CHIX:KURNz is CHF27.80 and 52 week low is CHF2.79.
When is next earnings date of Kuros Biosciences Ltd(CHIX:KURNz)?
The next earnings date of Kuros Biosciences Ltd(CHIX:KURNz) is .
Does Kuros Biosciences Ltd(CHIX:KURNz) pay dividends? If so, how much?
Kuros Biosciences Ltd(CHIX:KURNz) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers